Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease
Josep‐María Ribera(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), José‐Ángel Hernández‐Rivas(Hospital Universitario Infanta Leonor), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Albert Oriol(Institut Català d'Oncologia), Javier Grau, Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Montserrat Batlle(Centro de Investigación en Red en Enfermedades Cardiovasculares), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Eugènia Abella(Hospital Del Mar), Armando López‐Guillermo(Barcelona Supercomputing Center)
Cited by 38
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k